S.C. Ropharma Balance Sheet Health
Financial Health criteria checks 6/6
S.C. Ropharma has a total shareholder equity of RON251.9M and total debt of RON70.4M, which brings its debt-to-equity ratio to 28%. Its total assets and total liabilities are RON807.8M and RON555.9M respectively. S.C. Ropharma's EBIT is RON20.0M making its interest coverage ratio 3.7. It has cash and short-term investments of RON16.5M.
Key information
28.0%
Debt to equity ratio
RON 70.44m
Debt
Interest coverage ratio | 3.7x |
Cash | RON 16.51m |
Equity | RON 251.85m |
Total liabilities | RON 555.92m |
Total assets | RON 807.78m |
Recent financial health updates
Is S.C. Ropharma (BVB:RPH) Using Too Much Debt?
Jun 01S.C. Ropharma (BVB:RPH) Takes On Some Risk With Its Use Of Debt
May 15Recent updates
Here's What's Concerning About S.C. Ropharma's (BVB:RPH) Returns On Capital
Dec 09S.C. Ropharma (BVB:RPH) Is Reinvesting At Lower Rates Of Return
Sep 23Is S.C. Ropharma (BVB:RPH) Using Too Much Debt?
Jun 01Some Investors May Be Worried About S.C. Ropharma's (BVB:RPH) Returns On Capital
Mar 16S.C. Ropharma (BVB:RPH) Takes On Some Risk With Its Use Of Debt
May 15S.C. Ropharma (BVB:RPH) Might Be Having Difficulty Using Its Capital Effectively
Mar 26Should You Be Impressed By S.C. Ropharma's (BVB:RPH) Returns on Capital?
Dec 23We Wouldn't Rely On S.C. Ropharma's (BVB:RPH) Statutory Earnings As A Guide
Nov 24Financial Position Analysis
Short Term Liabilities: RPH's short term assets (RON452.0M) exceed its short term liabilities (RON445.6M).
Long Term Liabilities: RPH's short term assets (RON452.0M) exceed its long term liabilities (RON110.4M).
Debt to Equity History and Analysis
Debt Level: RPH's net debt to equity ratio (21.4%) is considered satisfactory.
Reducing Debt: RPH's debt to equity ratio has reduced from 37.6% to 28% over the past 5 years.
Debt Coverage: RPH's debt is well covered by operating cash flow (57.5%).
Interest Coverage: RPH's interest payments on its debt are well covered by EBIT (3.7x coverage).